Characteristics of Pseudomonas haemolysin.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000917:Antibody Formation; D000918:Antibody Specificity; D006460:Hemolysin Proteins / Q000008:administration & dosage / Q000096:biosynthesis / Q000302:isolation & purification; D007106:Immune Sera; D007114:Immunization; D007116:Immunization, Passive; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D051379:Mice; D008826:Microbial Sensitivity Tests; D011549:Pseudomonas / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D011552:Pseudomonas Infections / Q000517:prevention & control / Q000628:therapy; D011817:Rabbits / Q000276:immunology
D000900:Anti-Bacterial Agents; D006460:Hemolysin Proteins; D007106:Immune Sera